Scientific Advisory Board
Ken Melmon, M.D., Chief Medical Officer and Director of Research, Skolar, M.D.
Edward (Ted) Shortliffe, M.D., Ph.D., Dept. Head, Medical Informatics, Columbia University
Baruch Blumberg, M.D., Nobel Laureate in Physiology and Medicine, NASA
Joshua Lederberg, Ph.D., Nobel Laureate in Physiology and Medicine, Rockefeller University
Mark Davis, Ph.D., Howard Hughes Professor of Immunology, Stanford University
Arthur Atkinson, M.D., Senior Advisor in Clinical Pharmacology to the Director at NIH
Alan Garber, M.D., Ph.D., Professor of Medicine and Economics, Stanford University
Jeffrey Ullman, Ph.D., Professor, Department of Computer Science, Stanford University
Anthony Allison, D. Phil., Dr. Med., FormerVice President of Research, Syntex Pharmaceuticals
William Finkle, Ph.D., Consolidated Research, Consultants in Clinical Trial Design and Outcomes Research
Richard Lerner, M.D., President, Scripps Research Institute
Willem Stemmer, Ph.D., Vice President of Research, Maxygen Corporation
John Urquhart, Ph.D., Chief Scientist, APREX division of AARDEX Ltd., Professor of Pharmacoepidemiology, Maastricht University
Andrew Ewing, Ph.D., J. Lloyd Huck Chair in Natural Sciences, Penn State University, Head, Department of Chemistry, Penn State University
Ken Melmon, M.D., Chief Medical Officer and Director of Research, Skolar, M.D.
Edward (Ted) Shortliffe, M.D., Ph.D., Dept. Head, Medical Informatics, Columbia University
Baruch Blumberg, M.D., Nobel Laureate in Physiology and Medicine, NASA
Joshua Lederberg, Ph.D., Nobel Laureate in Physiology and Medicine, Rockefeller University
Mark Davis, Ph.D., Howard Hughes Professor of Immunology, Stanford University
Arthur Atkinson, M.D., Senior Advisor in Clinical Pharmacology to the Director at NIH
Alan Garber, M.D., Ph.D., Professor of Medicine and Economics, Stanford University
Jeffrey Ullman, Ph.D., Professor, Department of Computer Science, Stanford University
Anthony Allison, D. Phil., Dr. Med., FormerVice President of Research, Syntex Pharmaceuticals
William Finkle, Ph.D., Consolidated Research, Consultants in Clinical Trial Design and Outcomes Research
Richard Lerner, M.D., President, Scripps Research Institute
Willem Stemmer, Ph.D., Vice President of Research, Maxygen Corporation
John Urquhart, Ph.D., Chief Scientist, APREX division of AARDEX Ltd., Professor of Pharmacoepidemiology, Maastricht University
Andrew Ewing, Ph.D., J. Lloyd Huck Chair in Natural Sciences, Penn State University, Head, Department of Chemistry, Penn State University
